Evidence map›Paper›PMID 39138691›Full record

ArticlePediatric nephrology (Berlin, Germany)2025

Genetic study of Alport syndrome in Tunisia.

Mariem El Younsi, Ahlem Achour, Lilia Kraoua, Mezzi Nesrine, Taha Sayari, Ezzeddine Abderrahim, Janet Laabidi, Mohamed Karim Zouaghi, Maher Kharrat, Tahar Gargah and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mariem El YounsiLaboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
Ahlem AchourLaboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
Lilia KraouaLaboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
Mezzi NesrineLaboratory of Biomedical Genomics and Oncogenetics, Pasteur Institute of Tunis, 1002, Tunis, Tunisia.
Taha SayariService de Néphrologie Pédiatrique, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
Ezzeddine AbderrahimService de Médecine Interne Et de Néphrologie Adulte, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
Janet LaabidiService Néphrologie, L'Hôpital Militaire Principal d'Instruction de Tunis, MontFleury, 1008, Tunis, Tunisia.
Mohamed Karim ZouaghiService de Néphrologie, Dialyse Et Transplantation Rénale, Hôpital La Rabta 1007, Tunis, Tunisia.
Maher KharratLaboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
Tahar GargahService de Néphrologie Pédiatrique, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
Mediha TrabelsiLaboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
Ridha M'radLaboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia. ridha.mrad@rns.tn.ORCID http://orcid.org/0000-0001-5842-5536

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlport syndrome is a genetic disorder affecting the kidneys, ears, and eyes, causing chronic kidney disease, sensorineural hearing loss, and ocular abnormalities. It results from pathogenic variants in the COL4A3, COL4A4, or COL4A5 genes, with different inheritance patterns: X-linked from COL4A5 variants, autosomal recessive from homozygous variants in COL4A3 or COL4A4, digenic from variants in both COL4A3 and COL4A4, and autosomal dominant from heterozygous variants in COL4A3 or COL4A4.

methodsWe analyzed 45 patients with Alport syndrome from 11 Tunisian families to determine their clinical and genetic characteristics. Clinical data were collected retrospectively, and whole-exome sequencing was conducted on one patient from each family. Sanger sequencing validated pathogenic variants, and cascade screening extended the analysis to 53 individuals.

resultsWe identified nine likely pathogenic variants among 11 index cases: six novel and three known variations. Of these, five were in COL4A3, and four were in COL4A5, with variants including frameshift, nonsense, missense, and alternative splicing. Most variations affected the Gly-XY codon. Among the 45 clinically identified siblings, 30 tested positive for Alport syndrome. The cascade screening identified 3 additional affected individuals, 10 unaffected siblings, and 10 unaffected parents. The mode of inheritance was autosomal recessive in six families and X-linked in four families.

conclusionsThis study is the first to screen the mutational spectrum of Alport syndrome in Tunisia. It reveals novel pathogenic variants and suggests that autosomal recessive inheritance may be more common in the Tunisian population than X-linked inheritance, contrary to existing literature.

Indexed as

AutoantigensCollagen Type IVExome SequencingNephritis, HereditaryPedigreeAdolescentAdultChildChild, PreschoolFemaleHumansMaleMutationRetrospective StudiesTunisiaYoung AdultAutoantigensCOL4A4 protein, humanCOL4A5 protein, humanCollagen Type IVtype IV collagen alpha3 chainAlport syndromeCOL4A3COL4A4COL4A5Tunisian patientsWES

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.